This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Next Gen Establishes Its Second 100% Owned Subsidiary, GreenRush Analytical Laboratories Inc

  • GreenRush Analytical Labs (GAL) is a wholly owned Subsidiary of Next Gen
  • The Mission of GreenRush Analytical Labs; is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.
  • The Vision of GreenRush Analytical Labs; is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America .
  • Proposed new Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers.
  • Anticipated new legislation in the United States for medical/recreational Marijuana and  Industrial Hemp can derive unprecedented growth in these new Multi-Billion Dollars industries

VANCOUVER, May 6, 2014 /CNW/ - Next Gen Metals Inc. ("Next Gen", the "Company") (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that it has established its second %100 owned subsidiary, GreenRush Analytical Laboratories Inc. (GAL). The Mission of GreenRush Analytical Laboratories Inc. is to provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

Next Gen's competitive advantages include:

  1. Management's financial contacts to raise venture capital
  2. Management's ability to efficiently manage both public and private companies on an International scale
  3. Management's ability to negotiate equitable deals for our shareholders and partners
  4. Management's ability to Complete its objectives on time and on budget

GAL is organizing a team of scientists and laboratory technicians to staff our first Laboratory. Simultaneously GAL's management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,076.27 +64.33 0.36%
S&P 500 2,114.07 +4.47 0.21%
NASDAQ 5,099.2310 +22.7070 0.45%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs